chrX-13319240-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001135995.2(ATXN3L):c.695C>T(p.Ala232Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000364 in 1,209,333 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000063 ( 0 hom., 3 hem., cov: 22)
Exomes 𝑓: 0.000034 ( 0 hom. 9 hem. )
Consequence
ATXN3L
NM_001135995.2 missense
NM_001135995.2 missense
Scores
3
14
Clinical Significance
Conservation
PhyloP100: 6.14
Genes affected
ATXN3L (HGNC:24173): (ataxin 3 like) This intronless gene may be a pseudogene (PMID:11450850). This gene is similar to the multi-exon gene which encodes ataxin 3 and contains a coding region which could encode a protein similar to ataxin 3. Mutations in the gene encoding ataxin 3 are associated with Machado-Joseph disease. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.07308301).
BS2
High Hemizygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN3L | NM_001135995.2 | c.695C>T | p.Ala232Val | missense_variant | 1/1 | ENST00000380622.5 | NP_001129467.1 | |
ATXN3L | NM_001387036.1 | c.431C>T | p.Ala144Val | missense_variant | 2/2 | NP_001373965.1 | ||
GS1-600G8.3 | NR_046087.1 | n.1681G>A | non_coding_transcript_exon_variant | 16/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN3L | ENST00000380622.5 | c.695C>T | p.Ala232Val | missense_variant | 1/1 | 6 | NM_001135995.2 | ENSP00000369996.2 | ||
GS1-600G8.3 | ENST00000431486.1 | n.1681G>A | non_coding_transcript_exon_variant | 16/17 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000626 AC: 7AN: 111775Hom.: 0 Cov.: 22 AF XY: 0.0000883 AC XY: 3AN XY: 33963
GnomAD3 genomes
AF:
AC:
7
AN:
111775
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
33963
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000150 AC: 27AN: 180116Hom.: 0 AF XY: 0.0000900 AC XY: 6AN XY: 66682
GnomAD3 exomes
AF:
AC:
27
AN:
180116
Hom.:
AF XY:
AC XY:
6
AN XY:
66682
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000337 AC: 37AN: 1097558Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 9AN XY: 362994
GnomAD4 exome
AF:
AC:
37
AN:
1097558
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
362994
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000626 AC: 7AN: 111775Hom.: 0 Cov.: 22 AF XY: 0.0000883 AC XY: 3AN XY: 33963
GnomAD4 genome
AF:
AC:
7
AN:
111775
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
33963
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
19
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2024 | The c.695C>T (p.A232V) alteration is located in exon 1 (coding exon 1) of the ATXN3L gene. This alteration results from a C to T substitution at nucleotide position 695, causing the alanine (A) at amino acid position 232 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Benign
T
PROVEAN
Uncertain
N
REVEL
Benign
Sift
Benign
D
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Loss of helix (P = 0.2022);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at